Los Angeles County-Harbor-UCLA Medical Center Infectious Disease

Topics

• Antifungal resistance and susceptibility 215
• HIV Research and Treatment 105
• Antimicrobial Resistance in Staphylococcus 96
• HIV/AIDS Research and Interventions 90
• HIV-related health complications and treatments 90
• HIV/AIDS drug development and treatment 73
• SARS-CoV-2 and COVID-19 Research 38
• Hepatitis C virus research 26
• Fungal Infections and Studies 24
• Antibiotic Resistance in Bacteria 20
• COVID-19 Clinical Research Studies 18
• Urinary Tract Infections Management 17

Most cited

1. Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.

   The New England journal of medicine · 2021 · 759 citations · Eric Daar

2. Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.

   The New England journal of medicine · 2021 · 549 citations · Eric Daar

3. Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors.

   BMJ open diabetes research & care · 2023 · 120 citations · Erica Chow

4. HepB-CpG vs HepB-Alum Vaccine in People With HIV and Prior Vaccine Nonresponse: The BEe-HIVe Randomized Clinical Trial.

   JAMA · 2025 · 44 citations · Timothy Hatlen

5. Dalbavancin for Treatment of Staphylococcus aureus Bacteremia: The DOTS Randomized Clinical Trial.

   JAMA · 2025 · 41 citations · Loren Miller, James McKinnell

6. Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19.

   Science translational medicine · 2021 · 199 citations · Scott Layne